| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.11M | 3.11M | 2.91M | 2.73M | 2.76M | 2.99M |
| Gross Profit | 3.05M | 3.11M | 2.91M | 2.58M | 2.76M | 2.99M |
| EBITDA | 785.10K | 785.10K | 1.25M | 1.14M | 925.78K | 1.21M |
| Net Income | 943.43K | 943.43K | 1.07M | 980.11K | 610.57K | 1.05M |
Balance Sheet | ||||||
| Total Assets | 10.82M | 10.82M | 10.56M | 9.03M | 8.78M | 8.57M |
| Cash, Cash Equivalents and Short-Term Investments | 7.40M | 7.40M | 7.16M | 6.41M | 6.03M | 5.40M |
| Total Debt | 427.36K | 427.36K | 537.67K | 40.32K | 195.85K | 344.30K |
| Total Liabilities | 2.09M | 2.09M | 2.30M | 1.42M | 1.80M | 1.99M |
| Stockholders Equity | 8.73M | 8.73M | 8.27M | 7.61M | 6.97M | 6.58M |
Cash Flow | ||||||
| Free Cash Flow | 597.31K | 597.31K | 1.02M | 974.92K | 1.12M | 813.13K |
| Operating Cash Flow | 606.41K | 606.41K | 1.04M | 978.40K | 1.12M | 814.62K |
| Investing Cash Flow | -9.11K | 240.71K | 236.26K | 73.50K | 11.22K | 11.78K |
| Financing Cash Flow | -611.79K | -611.79K | -522.92K | -590.14K | -487.18K | -424.64K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £16.03M | 8.65 | 28.74% | 5.18% | ― | ― | |
70 Outperform | £11.70M | 12.39 | 11.10% | 4.73% | 6.76% | -11.53% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | £9.62M | -3.44 | -32.98% | ― | -9.19% | 4.69% | |
47 Neutral | £9.51M | -1.96 | -52.41% | ― | -31.21% | -292.31% | |
47 Neutral | £9.83M | -1.88 | -32.23% | ― | -7.72% | 54.13% | |
47 Neutral | £9.40M | -1.68 | ― | ― | -5.21% | 76.14% |
Arcontech Group has granted 262,500 share options under its EMI and non-EMI schemes to various employees, including senior management such as the chief executive, chief financial officer, head of development and head of customer support, at an exercise price of 84.50p per share, exercisable from 30 June 2028. The options, which are subject to the company achieving £4 million in annual revenue by the end of the 2027/28 financial year and must be held for two years after exercise, lift the total outstanding options to 803,000, equivalent to about 6% of Arcontech’s issued share capital, further aligning key staff incentives with the company’s medium-term growth and revenue targets.
The most recent analyst rating on (GB:ARC) stock is a Buy with a £95.00 price target. To see the full list of analyst forecasts on Arcontech stock, see the GB:ARC Stock Forecast page.